| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-11 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0005 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.56 | 0.002 |